CIK: 0001583977 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value ($000): $1,322,563 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | TURNING POINT THERAPEUTICS I | 2,484,220 | $186,938 | 14.1% | $45.88 | — | COM | 90041T108 |
| DSGN | DESIGN THERAPEUTICS INC | 5,500,000 | $77,000 | 5.8% | $29.56 | -54.3% | COM | 25056L103 |
| ERAS | ERASCA INC | 10,505,554 | $58,516 | 4.4% | $20.63 | -68.3% | COM | 29479A108 |
| — | PROMETHEUS BIOSCIENCES INC | 2,029,158 | $57,283 | 4.3% | $18.55 | — | COM | 74349U108 |
| APLS | APELLIS PHARMACEUTICALS INC | 950,000 | $42,959 | 3.2% | $30.07 | +51.6% | COM | 03753U106 |
| RVMD | REVOLUTION MEDICINES INC | 1,995,066 | $38,884 | 2.9% | $29.60 | -34.2% | COM | 76155X100 |
| BMEA | BIOMEA FUSION INC | 3,170,872 | $37,987 | 2.9% | $17.65 | -66.8% | COM | 09077A106 |
| — | CHEMOCENTRYX INC | 1,425,000 | $35,312 | 2.7% | $28.14 | — | COM | 16383L106 |
| ALT | ALTIMMUNE INC | 3,000,000 | $35,100 | 2.7% | $6.17 | 0.0% | COM NEW | 02155H200 |
| XBI | SPDR SER TR | 450,000 | $33,422 | 2.5% | — | — | Call | 78464A870 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 6,065,001 | $30,886 | 2.3% | $6.29 | 0.0% | CLASS A ORD | 61559X104 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,850,000 | $30,646 | 2.3% | $25.59 | -70.5% | COM | 28036F105 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,012,115 | $29,236 | 2.2% | $28.83 | -48.4% | COM | 05370A108 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 2,993,717 | $28,949 | 2.2% | $20.37 | -50.7% | COM | 61225M102 |
| ACLX | ARCELLX INC | 1,525,000 | $27,572 | 2.1% | $12.90 | 0.0% | COMMON STOCK | 03940C100 |
| TARS | TARSUS PHARMACEUTICALS INC | 1,875,000 | $27,375 | 2.1% | $24.90 | -39.7% | COM | 87650L103 |
| — | AEROVATE THERAPEUTICS INC | 1,730,691 | $27,051 | 2.0% | $21.97 | — | COM | 008064107 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 184,894 | $26,941 | 2.0% | $133.97 | — | COM | G11196105 |
| — | ADICET BIO INC | 1,800,000 | $26,280 | 2.0% | $15.80 | — | COM | 007002108 |
| PHVS | PHARVARIS N V | 1,145,953 | $25,326 | 1.9% | $26.30 | -29.2% | COM | N69605108 |
| — | FORMA THERAPEUTICS HLDGS INC | 3,172,204 | $21,856 | 1.7% | $41.85 | — | SHS | 34633R104 |
| — | HORIZON THERAPEUTICS PUB L | 267,500 | $21,336 | 1.6% | $89.27 | — | SHS | G46188101 |
| TNGX | TANGO THERAPEUTICS INC | 4,507,843 | $20,421 | 1.5% | $11.99 | -49.5% | COM | 87583X109 |
| — | MIRATI THERAPEUTICS INC | 300,000 | $20,139 | 1.5% | $67.06 | — | COM | 60468T105 |
| — | AXONICS INC | 322,240 | $18,261 | 1.4% | $15.11 | — | COM | 05465P101 |
| — | KARUNA THERAPEUTICS INC | 125,000 | $15,814 | 1.2% | $126.79 | — | COM | 48576A100 |
| CYTK | CYTOKINETICS INC | 400,000 | $15,716 | 1.2% | $29.44 | +36.7% | COM NEW | 23282W605 |
| — | INTRA-CELLULAR THERAPIES INC | 275,000 | $15,697 | 1.2% | $59.32 | — | COM | 46116X101 |
| — | VECTIVBIO HLDG AG | 2,840,389 | $15,338 | 1.2% | $9.84 | — | ORD SHS | H9060V101 |
| — | GREENLIGHT BIOSCIENCS HLDS P | 6,960,540 | $15,234 | 1.2% | $8.99 | — | COMMON STOCK | 39536G105 |
| STOK | STOKE THERAPEUTICS INC | 1,087,807 | $14,370 | 1.1% | $26.85 | -43.4% | COM | 86150R107 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,927,273 | $14,256 | 1.1% | $15.97 | — | SPONSORED ADS | 152309100 |
| BBIO | BRIDGEBIO PHARMA INC | 1,469,179 | $13,340 | 1.0% | $27.82 | -69.9% | COM | 10806X102 |
| — | RAIN THERAPEUTICS INC | 2,326,660 | $12,936 | 1.0% | $15.13 | — | COM | 75082Q105 |
| IMRX | IMMUNEERING CORP | 2,286,181 | $12,368 | 0.9% | $26.82 | -80.1% | CLASS A COM | 45254E107 |
| RCKT | ROCKET PHARMACEUTICALS INC | 868,550 | $11,951 | 0.9% | $16.47 | -27.6% | COM | 77313F106 |
| — | SPRINGWORKS THERAPEUTICS INC | 475,000 | $11,694 | 0.9% | $24.62 | — | COM | 85205L107 |
| AVIR | ATEA PHARMACEUTICALS INC | 1,547,181 | $10,985 | 0.8% | $32.23 | -78.8% | COM | 04683R106 |
| — | VERVE THERAPEUTICS INC | 700,710 | $10,707 | 0.8% | $49.89 | — | COM | 92539P101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 877,500 | $10,153 | 0.8% | $19.07 | -29.5% | COM | 92790C104 |
| — | KEZAR LIFE SCIENCES INC | 1,200,000 | $9,924 | 0.8% | $8.27 | — | COM | 49372L100 |
| VTYX | VENTYX BIOSCIENCES INC | 780,643 | $9,547 | 0.7% | $18.95 | -21.1% | COM | 92332V107 |
| OLMA | OLEMA PHARMACEUTICALS INC | 2,082,000 | $8,474 | 0.6% | $46.89 | -93.2% | COM | 68062P106 |
| AXSM | AXSOME THERAPEUTICS INC | 205,000 | $7,852 | 0.6% | $31.63 | 0.0% | COM | 05464T104 |
| — | LONGBOARD PHARMACEUTICALS IN | 2,273,221 | $7,024 | 0.5% | $15.79 | — | COM | 54300N103 |
| COGT | COGENT BIOSCIENCES INC | 750,000 | $6,765 | 0.5% | $6.83 | 0.0% | COM | 19240Q201 |
| — | AMBRX BIOPHARMA INC | 2,486,386 | $6,589 | 0.5% | $18.92 | — | SPONSORED ADS | 02290A102 |
| GHRS | GH RESEARCH PLC | 608,123 | $6,069 | 0.5% | $20.43 | -36.4% | ORDINARY SHARES | G3855L106 |
| BCAB | BIOATLA INC | 2,038,215 | $5,809 | 0.4% | $29.04 | -89.0% | COM | 09077B104 |
| ALXO | ALX ONCOLOGY HLDGS INC | 712,079 | $5,761 | 0.4% | $42.62 | -74.4% | COM | 00166B105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 200,000 | $5,392 | 0.4% | $29.04 | 0.0% | COM NEW | 15117B202 |
| TYRA | TYRA BIOSCIENCES INC | 743,988 | $5,320 | 0.4% | $19.11 | -58.3% | COM | 90240B106 |
| — | TALARIS THERAPEUTICS INC | 1,174,723 | $5,298 | 0.4% | $14.20 | — | COM | 87410C104 |
| ASND | ASCENDIS PHARMA A/S | 50,000 | $4,648 | 0.4% | $124.16 | — | SPONSORED ADR | 04351P101 |
| PLRX | PLIANT THERAPEUTICS INC | 482,413 | $3,864 | 0.3% | $26.54 | -75.9% | COM | 729139105 |
| — | AKERO THERAPEUTICS INC | 403,787 | $3,816 | 0.3% | $22.77 | — | COM | 00973Y108 |
| — | ICOSAVAX INC | 651,393 | $3,732 | 0.3% | $20.77 | — | COM | 45114M109 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,305,095 | $3,184 | 0.2% | $15.09 | -79.8% | COM | 28617K101 |
| — | ELEVATION ONCOLOGY INC | 1,983,168 | $2,776 | 0.2% | $12.89 | — | COM | 28623U101 |
| KROS | KEROS THERAPEUTICS INC | 100,000 | $2,763 | 0.2% | $49.87 | -12.0% | COM | 492327101 |
| — | Y-MABS THERAPEUTICS INC | 150,000 | $2,270 | 0.2% | $31.28 | — | COM | 984241109 |
| — | AKOUOS INC | 394,500 | $1,850 | 0.1% | $21.34 | — | COM | 00973J101 |
| — | GALECTO INC | 1,020,238 | $1,765 | 0.1% | $12.30 | — | COM | 36322Q107 |
| GOSS | GOSSAMER BIO INC | 198,382 | $1,660 | 0.1% | $12.02 | -35.6% | COM | 38341P102 |
| PYXS | PYXIS ONCOLOGY INC | 668,854 | $1,592 | 0.1% | $11.45 | -76.7% | COMMON STOCK | 747324101 |
| — | VIGIL NEUROSCIENCE INC | 616,786 | $1,591 | 0.1% | $6.82 | — | COM | 92673K108 |
| CABA | CABALETTA BIO INC | 1,154,424 | $1,224 | 0.1% | $11.85 | -88.1% | COM | 12674W109 |
| MGTX | MEIRAGTX HLDGS PLC | 150,000 | $1,136 | 0.1% | $19.14 | -49.3% | COM | G59665102 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 392,167 | $1,110 | 0.1% | $31.47 | — | SPON ADS | 05280R100 |
| — | CHEMOMAB THERAPEUTICS LTD | 288,168 | $1,066 | 0.1% | $4.80 | — | SPONSORED ADS | 16385C104 |
| — | HARPOON THERAPEUTICS INC | 540,600 | $1,033 | 0.1% | $9.47 | — | COM | 41358P106 |
| ANAB | ANAPTYSBIO INC | 50,000 | $1,015 | 0.1% | $23.10 | -4.1% | COM | 032724106 |
| — | RENOVACOR INC | 500,000 | $1,014 | 0.1% | $9.05 | — | COM | 75989E106 |
| GLSHQ | GELESIS HLDGS INC | 626,108 | $970 | 0.1% | $4.31 | -4.2% | COM | 36850R204 |
| — | ASTRIA THERAPEUTICS INC | 300,000 | $900 | 0.1% | $8.84 | — | COM | 04635X102 |
| — | ATRECA INC | 319,057 | $571 | 0.0% | $8.53 | — | CL A COM | 04965G109 |
| — | GRAPHITE BIO INC | 199,547 | $549 | 0.0% | $29.19 | — | COM | 38870X104 |
| — | IMV INC | 234,374 | $155 | 0.0% | $3.05 | — | COM | 44974L103 |
| — | ORCHARD THERAPEUTICS PLC | 256,649 | $150 | 0.0% | $16.35 | — | ADS | 68570P101 |
| — | X4 PHARMACEUTICALS INC | 103,980 | $100 | 0.0% | $6.43 | — | COM | 98420X103 |